Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders.
Altintas MM, Agarwal S, Sudhini Y, Zhu K, Wei C, Reiser J.
Annu Rev Pathol. 2025 Jan;20(1):329-353. doi: 10.1146/annurev-pathol-051220-092001.
Podocyte injury and its consequences.
Nagata M.
Kidney Int. 2016 Jun;89(6):1221-30. doi: 10.1016/j.kint.2016.01.012. Epub 2016 Mar 19.
Role of Podocyte in Kidney Disease.
Husain S.
Front Biosci (Landmark Ed). 2024 Jul 11;29(7):250. doi: 10.31083/j.fbl2907250.
Podocytopathies.
Navarro-Torres M, Wooden B, Santoriello D, Radhakrishnan J, Bomback AS.
Adv Kidney Dis Health. 2025 Jan;32(1):2-11. doi: 10.1053/j.akdh.2024.10.004.
A kidney organoid-based readout to assess disease activity in primary and recurrent focal segmental glomerulosclerosis.
Gupta AK, Minocha E, Koss KM, Naved BA, Safar-Boueri L, Wertheim JA, Gallon L.
Kidney Int. 2025 May;107(5):888-902. doi: 10.1016/j.kint.2025.01.018. Epub 2025 Feb 4.
Drug-induced glomerular diseases.
Garnier AS, Laubacher H, Briet M.
Therapie. 2024 Mar-Apr;79(2):271-281. doi: 10.1016/j.therap.2023.10.010. Epub 2023 Oct 31.
Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence.
Randone P, Sanna E, Dolla C, Gallo E, Mingozzi S, Tarragoni R, Torazza MC, Niarchos A, Mella A, Manzione AM, Barreca A, Deambrosis I, Giraudi R, Biancone L.
Am J Transplant. 2024 Oct;24(10):1896-1900. doi: 10.1016/j.ajt.2024.06.010. Epub 2024 Jul 17.
Obesity-related kidney disease.
Snyder S, Turner GA, Turner A.
Prim Care. 2014 Dec;41(4):875-93. doi: 10.1016/j.pop.2014.08.008. Epub 2014 Oct 3.
Autophagy and podocytopathy.
Ponticelli C, Moroni G, Reggiani F.
Nephrol Dial Transplant. 2023 Aug 31;38(9):1931-1939. doi: 10.1093/ndt/gfad024.
Slit Diaphragms: Junctions That Never Sleep.
Drummond IA.
J Am Soc Nephrol. 2022 Dec;33(12):2127-2128. doi: 10.1681/ASN.2022101147. Epub 2022 Nov 4.
